img

Global Human Coagulation Factor IX Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Coagulation Factor IX Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Human Coagulation Factor IX report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Human Coagulation Factor IX market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Personal Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Human Coagulation Factor IX industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Human Coagulation Factor IX key manufacturers include Grifols, Biogen, Octapharma, Baxter, Bayer, CSL, Novo Nordisk, Greencross and Kedrion, etc. Grifols, Biogen, Octapharma are top 3 players and held % sales share in total in 2022.
Human Coagulation Factor IX can be divided into AHGB, AHFB and Others,, etc. AHGB is the mainstream product in the market, accounting for % sales share globally in 2022.
Human Coagulation Factor IX is widely used in various fields, such as Hospital, Personal Clinic and Others,, etc. Hospital provides greatest supports to the Human Coagulation Factor IX industry development. In 2022, global % sales of Human Coagulation Factor IX went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Coagulation Factor IX market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Grifols
Biogen
Octapharma
Baxter
Bayer
CSL
Novo Nordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Pfizer
Segment by Type
AHGB
AHFB
Others

Segment by Application


Hospital
Personal Clinic
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Human Coagulation Factor IX market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Human Coagulation Factor IX, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Human Coagulation Factor IX industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Human Coagulation Factor IX in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Human Coagulation Factor IX introduction, etc. Human Coagulation Factor IX Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Human Coagulation Factor IX market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Human Coagulation Factor IX Market Overview
1.1 Human Coagulation Factor IX Product Overview
1.2 Human Coagulation Factor IX Market Segment by Type
1.2.1 AHGB
1.2.2 AHFB
1.2.3 Others
1.3 Global Human Coagulation Factor IX Market Size by Type
1.3.1 Global Human Coagulation Factor IX Market Size Overview by Type (2018-2034)
1.3.2 Global Human Coagulation Factor IX Historic Market Size Review by Type (2018-2024)
1.3.3 Global Human Coagulation Factor IX Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Coagulation Factor IX Sales Breakdown by Type (2018-2024)
1.4.2 Europe Human Coagulation Factor IX Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Human Coagulation Factor IX Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Human Coagulation Factor IX Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Human Coagulation Factor IX Sales Breakdown by Type (2018-2024)
2 Global Human Coagulation Factor IX Market Competition by Company
2.1 Global Top Players by Human Coagulation Factor IX Sales (2018-2024)
2.2 Global Top Players by Human Coagulation Factor IX Revenue (2018-2024)
2.3 Global Top Players by Human Coagulation Factor IX Price (2018-2024)
2.4 Global Top Manufacturers Human Coagulation Factor IX Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Coagulation Factor IX Market Competitive Situation and Trends
2.5.1 Human Coagulation Factor IX Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Coagulation Factor IX Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Coagulation Factor IX as of 2022)
2.7 Date of Key Manufacturers Enter into Human Coagulation Factor IX Market
2.8 Key Manufacturers Human Coagulation Factor IX Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Coagulation Factor IX Status and Outlook by Region
3.1 Global Human Coagulation Factor IX Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Human Coagulation Factor IX Historic Market Size by Region
3.2.1 Global Human Coagulation Factor IX Sales in Volume by Region (2018-2024)
3.2.2 Global Human Coagulation Factor IX Sales in Value by Region (2018-2024)
3.2.3 Global Human Coagulation Factor IX Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Human Coagulation Factor IX Forecasted Market Size by Region
3.3.1 Global Human Coagulation Factor IX Sales in Volume by Region (2024-2034)
3.3.2 Global Human Coagulation Factor IX Sales in Value by Region (2024-2034)
3.3.3 Global Human Coagulation Factor IX Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Human Coagulation Factor IX by Application
4.1 Human Coagulation Factor IX Market Segment by Application
4.1.1 Hospital
4.1.2 Personal Clinic
4.1.3 Others
4.2 Global Human Coagulation Factor IX Market Size by Application
4.2.1 Global Human Coagulation Factor IX Market Size Overview by Application (2018-2034)
4.2.2 Global Human Coagulation Factor IX Historic Market Size Review by Application (2018-2024)
4.2.3 Global Human Coagulation Factor IX Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Coagulation Factor IX Sales Breakdown by Application (2018-2024)
4.3.2 Europe Human Coagulation Factor IX Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Human Coagulation Factor IX Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Human Coagulation Factor IX Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Human Coagulation Factor IX Sales Breakdown by Application (2018-2024)
5 North America Human Coagulation Factor IX by Country
5.1 North America Human Coagulation Factor IX Historic Market Size by Country
5.1.1 North America Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Human Coagulation Factor IX Sales in Volume by Country (2018-2024)
5.1.3 North America Human Coagulation Factor IX Sales in Value by Country (2018-2024)
5.2 North America Human Coagulation Factor IX Forecasted Market Size by Country
5.2.1 North America Human Coagulation Factor IX Sales in Volume by Country (2024-2034)
5.2.2 North America Human Coagulation Factor IX Sales in Value by Country (2024-2034)
6 Europe Human Coagulation Factor IX by Country
6.1 Europe Human Coagulation Factor IX Historic Market Size by Country
6.1.1 Europe Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Human Coagulation Factor IX Sales in Volume by Country (2018-2024)
6.1.3 Europe Human Coagulation Factor IX Sales in Value by Country (2018-2024)
6.2 Europe Human Coagulation Factor IX Forecasted Market Size by Country
6.2.1 Europe Human Coagulation Factor IX Sales in Volume by Country (2024-2034)
6.2.2 Europe Human Coagulation Factor IX Sales in Value by Country (2024-2034)
7 Asia-Pacific Human Coagulation Factor IX by Region
7.1 Asia-Pacific Human Coagulation Factor IX Historic Market Size by Region
7.1.1 Asia-Pacific Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Human Coagulation Factor IX Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Human Coagulation Factor IX Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Human Coagulation Factor IX Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Coagulation Factor IX Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Human Coagulation Factor IX Sales in Value by Region (2024-2034)
8 Latin America Human Coagulation Factor IX by Country
8.1 Latin America Human Coagulation Factor IX Historic Market Size by Country
8.1.1 Latin America Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Human Coagulation Factor IX Sales in Volume by Country (2018-2024)
8.1.3 Latin America Human Coagulation Factor IX Sales in Value by Country (2018-2024)
8.2 Latin America Human Coagulation Factor IX Forecasted Market Size by Country
8.2.1 Latin America Human Coagulation Factor IX Sales in Volume by Country (2024-2034)
8.2.2 Latin America Human Coagulation Factor IX Sales in Value by Country (2024-2034)
9 Middle East and Africa Human Coagulation Factor IX by Country
9.1 Middle East and Africa Human Coagulation Factor IX Historic Market Size by Country
9.1.1 Middle East and Africa Human Coagulation Factor IX Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Human Coagulation Factor IX Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Human Coagulation Factor IX Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Human Coagulation Factor IX Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Coagulation Factor IX Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Human Coagulation Factor IX Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Grifols
10.1.1 Grifols Company Information
10.1.2 Grifols Introduction and Business Overview
10.1.3 Grifols Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Grifols Human Coagulation Factor IX Products Offered
10.1.5 Grifols Recent Development
10.2 Biogen
10.2.1 Biogen Company Information
10.2.2 Biogen Introduction and Business Overview
10.2.3 Biogen Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Biogen Human Coagulation Factor IX Products Offered
10.2.5 Biogen Recent Development
10.3 Octapharma
10.3.1 Octapharma Company Information
10.3.2 Octapharma Introduction and Business Overview
10.3.3 Octapharma Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Octapharma Human Coagulation Factor IX Products Offered
10.3.5 Octapharma Recent Development
10.4 Baxter
10.4.1 Baxter Company Information
10.4.2 Baxter Introduction and Business Overview
10.4.3 Baxter Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Baxter Human Coagulation Factor IX Products Offered
10.4.5 Baxter Recent Development
10.5 Bayer
10.5.1 Bayer Company Information
10.5.2 Bayer Introduction and Business Overview
10.5.3 Bayer Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bayer Human Coagulation Factor IX Products Offered
10.5.5 Bayer Recent Development
10.6 CSL
10.6.1 CSL Company Information
10.6.2 CSL Introduction and Business Overview
10.6.3 CSL Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.6.4 CSL Human Coagulation Factor IX Products Offered
10.6.5 CSL Recent Development
10.7 Novo Nordisk
10.7.1 Novo Nordisk Company Information
10.7.2 Novo Nordisk Introduction and Business Overview
10.7.3 Novo Nordisk Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Novo Nordisk Human Coagulation Factor IX Products Offered
10.7.5 Novo Nordisk Recent Development
10.8 Greencross
10.8.1 Greencross Company Information
10.8.2 Greencross Introduction and Business Overview
10.8.3 Greencross Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Greencross Human Coagulation Factor IX Products Offered
10.8.5 Greencross Recent Development
10.9 Kedrion
10.9.1 Kedrion Company Information
10.9.2 Kedrion Introduction and Business Overview
10.9.3 Kedrion Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Kedrion Human Coagulation Factor IX Products Offered
10.9.5 Kedrion Recent Development
10.10 BPL
10.10.1 BPL Company Information
10.10.2 BPL Introduction and Business Overview
10.10.3 BPL Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.10.4 BPL Human Coagulation Factor IX Products Offered
10.10.5 BPL Recent Development
10.11 Hualan Bio
10.11.1 Hualan Bio Company Information
10.11.2 Hualan Bio Introduction and Business Overview
10.11.3 Hualan Bio Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Hualan Bio Human Coagulation Factor IX Products Offered
10.11.5 Hualan Bio Recent Development
10.12 RAAS
10.12.1 RAAS Company Information
10.12.2 RAAS Introduction and Business Overview
10.12.3 RAAS Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.12.4 RAAS Human Coagulation Factor IX Products Offered
10.12.5 RAAS Recent Development
10.13 Pfizer
10.13.1 Pfizer Company Information
10.13.2 Pfizer Introduction and Business Overview
10.13.3 Pfizer Human Coagulation Factor IX Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Pfizer Human Coagulation Factor IX Products Offered
10.13.5 Pfizer Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Coagulation Factor IX Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Coagulation Factor IX Industrial Chain Analysis
11.4 Human Coagulation Factor IX Market Dynamics
11.4.1 Human Coagulation Factor IX Industry Trends
11.4.2 Human Coagulation Factor IX Market Drivers
11.4.3 Human Coagulation Factor IX Market Challenges
11.4.4 Human Coagulation Factor IX Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Coagulation Factor IX Distributors
12.3 Human Coagulation Factor IX Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of AHGB
Table 2. Major Company of AHFB
Table 3. Major Company of Others
Table 4. Global Human Coagulation Factor IX Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Human Coagulation Factor IX Sales by Type (2018-2024) & (K Pcs)
Table 6. Global Human Coagulation Factor IX Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Human Coagulation Factor IX Sales by Type (2018-2024) & (US& Million)
Table 8. Global Human Coagulation Factor IX Market Share in Value by Type (2018-2024)
Table 9. Global Human Coagulation Factor IX Price by Type (2018-2024) & (USD/Pcs)
Table 10. Global Human Coagulation Factor IX Sales by Type (2024-2034) & (K Pcs)
Table 11. Global Human Coagulation Factor IX Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Human Coagulation Factor IX Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Human Coagulation Factor IX Sales Market Share in Value by Type (2024-2034)
Table 14. Global Human Coagulation Factor IX Price by Type (2024-2034) & (USD/Pcs)
Table 15. North America Human Coagulation Factor IX Sales by Type (2018-2024) & (K Pcs)
Table 16. North America Human Coagulation Factor IX Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Human Coagulation Factor IX Sales (K Pcs) by Type (2018-2024)
Table 18. Europe Human Coagulation Factor IX Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Human Coagulation Factor IX Sales (K Pcs) by Type (2018-2024)
Table 20. Asia-Pacific Human Coagulation Factor IX Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Human Coagulation Factor IX Sales (K Pcs) by Type (2018-2024)
Table 22. Latin America Human Coagulation Factor IX Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Human Coagulation Factor IX Sales (K Pcs) by Type (2018-2024)
Table 24. Middle East and Africa Human Coagulation Factor IX Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Human Coagulation Factor IX Sales by Company (2018-2024) & (K Pcs)
Table 26. Global Human Coagulation Factor IX Sales Share by Company (2018-2024)
Table 27. Global Human Coagulation Factor IX Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Human Coagulation Factor IX Revenue Share by Company (2018-2024)
Table 29. Global Market Human Coagulation Factor IX Price by Company (2018-2024) & (USD/Pcs)
Table 30. Global Human Coagulation Factor IX Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Human Coagulation Factor IX Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Coagulation Factor IX as of 2022)
Table 33. Date of Key Manufacturers Enter into Human Coagulation Factor IX Market
Table 34. Key Manufacturers Human Coagulation Factor IX Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Human Coagulation Factor IX Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Human Coagulation Factor IX Sales by Region (2018-2024) & (K Pcs)
Table 38. Global Human Coagulation Factor IX Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Human Coagulation Factor IX Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Human Coagulation Factor IX Sales Market Share in Value by Region (2018-2024)
Table 41. Global Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 42. Global Human Coagulation Factor IX Sales by Region (2024-2034) & (K Pcs)
Table 43. Global Human Coagulation Factor IX Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Human Coagulation Factor IX Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Human Coagulation Factor IX Sales Market Share in Value by Region (2024-2034)
Table 46. Global Human Coagulation Factor IX Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 47. Global Human Coagulation Factor IX Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Human Coagulation Factor IX Sales by Application (2018-2024) & (K Pcs)
Table 49. Global Human Coagulation Factor IX Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Human Coagulation Factor IX Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Human Coagulation Factor IX Sales Market Share in Value by Application (2018-2024)
Table 52. Global Human Coagulation Factor IX Price by Application (2018-2024) & (USD/Pcs)
Table 53. Global Human Coagulation Factor IX Sales by Application (2024-2034) & (K Pcs)
Table 54. Global Human Coagulation Factor IX Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Human Coagulation Factor IX Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Human Coagulation Factor IX Sales Market Share in Value by Application (2024-2034)
Table 57. Global Human Coagulation Factor IX Price by Application (2024-2034) & (USD/Pcs)
Table 58. North America Human Coagulation Factor IX Sales by Application (2018-2024) (K Pcs)
Table 59. North America Human Coagulation Factor IX Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Human Coagulation Factor IX Sales by Application (2018-2024) (K Pcs)
Table 61. Europe Human Coagulation Factor IX Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Human Coagulation Factor IX Sales by Application (2018-2024) (K Pcs)
Table 63. Asia-Pacific Human Coagulation Factor IX Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Human Coagulation Factor IX Sales by Application (2018-2024) (K Pcs)
Table 65. Latin America Human Coagulation Factor IX Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Human Coagulation Factor IX Sales by Application (2018-2024) (K Pcs)
Table 67. Middle East and Africa Human Coagulation Factor IX Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Human Coagulation Factor IX Sales by Country (2018-2024) & (K Pcs)
Table 69. North America Human Coagulation Factor IX Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Human Coagulation Factor IX Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Human Coagulation Factor IX Sales Market Share in Value by Country (2018-2024)
Table 72. North America Human Coagulation Factor IX Sales by Country (2024-2034) & (K Pcs)
Table 73. North America Human Coagulation Factor IX Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Human Coagulation Factor IX Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Human Coagulation Factor IX Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Human Coagulation Factor IX Sales by Country (2018-2024) & (K Pcs)
Table 77. Europe Human Coagulation Factor IX Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Human Coagulation Factor IX Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Human Coagulation Factor IX Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Human Coagulation Factor IX Sales by Country (2024-2034) & (K Pcs)
Table 81. Europe Human Coagulation Factor IX Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Human Coagulation Factor IX Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Human Coagulation Factor IX Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Human Coagulation Factor IX Sales by Region (2018-2024) & (K Pcs)
Table 85. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Human Coagulation Factor IX Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Human Coagulation Factor IX Sales by Region (2024-2034) & (K Pcs)
Table 89. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Human Coagulation Factor IX Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Human Coagulation Factor IX Sales by Country (2018-2024) & (K Pcs)
Table 93. Latin America Human Coagulation Factor IX Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Human Coagulation Factor IX Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Human Coagulation Factor IX Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Human Coagulation Factor IX Sales by Country (2024-2034) & (K Pcs)
Table 97. Latin America Human Coagulation Factor IX Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Human Coagulation Factor IX Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Human Coagulation Factor IX Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Human Coagulation Factor IX Sales by Country (2018-2024) & (K Pcs)
Table 101. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Human Coagulation Factor IX Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Human Coagulation Factor IX Sales by Country (2024-2034) & (K Pcs)
Table 105. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Human Coagulation Factor IX Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Value by Country (2024-2034)
Table 108. Grifols Company Information
Table 109. Grifols Introduction and Business Overview
Table 110. Grifols Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 111. Grifols Human Coagulation Factor IX Product
Table 112. Grifols Recent Development
Table 113. Biogen Company Information
Table 114. Biogen Introduction and Business Overview
Table 115. Biogen Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 116. Biogen Human Coagulation Factor IX Product
Table 117. Biogen Recent Development
Table 118. Octapharma Company Information
Table 119. Octapharma Introduction and Business Overview
Table 120. Octapharma Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 121. Octapharma Human Coagulation Factor IX Product
Table 122. Octapharma Recent Development
Table 123. Baxter Company Information
Table 124. Baxter Introduction and Business Overview
Table 125. Baxter Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 126. Baxter Human Coagulation Factor IX Product
Table 127. Baxter Recent Development
Table 128. Bayer Company Information
Table 129. Bayer Introduction and Business Overview
Table 130. Bayer Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 131. Bayer Human Coagulation Factor IX Product
Table 132. Bayer Recent Development
Table 133. CSL Company Information
Table 134. CSL Introduction and Business Overview
Table 135. CSL Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 136. CSL Human Coagulation Factor IX Product
Table 137. CSL Recent Development
Table 138. Novo Nordisk Company Information
Table 139. Novo Nordisk Introduction and Business Overview
Table 140. Novo Nordisk Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 141. Novo Nordisk Human Coagulation Factor IX Product
Table 142. Novo Nordisk Recent Development
Table 143. Greencross Company Information
Table 144. Greencross Introduction and Business Overview
Table 145. Greencross Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 146. Greencross Human Coagulation Factor IX Product
Table 147. Greencross Recent Development
Table 148. Kedrion Company Information
Table 149. Kedrion Introduction and Business Overview
Table 150. Kedrion Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 151. Kedrion Human Coagulation Factor IX Product
Table 152. Kedrion Recent Development
Table 153. BPL Company Information
Table 154. BPL Introduction and Business Overview
Table 155. BPL Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 156. BPL Human Coagulation Factor IX Product
Table 157. BPL Recent Development
Table 158. Hualan Bio Company Information
Table 159. Hualan Bio Introduction and Business Overview
Table 160. Hualan Bio Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 161. Hualan Bio Human Coagulation Factor IX Product
Table 162. Hualan Bio Recent Development
Table 163. RAAS Company Information
Table 164. RAAS Introduction and Business Overview
Table 165. RAAS Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 166. RAAS Human Coagulation Factor IX Product
Table 167. RAAS Recent Development
Table 168. Pfizer Company Information
Table 169. Pfizer Introduction and Business Overview
Table 170. Pfizer Human Coagulation Factor IX Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 171. Pfizer Human Coagulation Factor IX Product
Table 172. Pfizer Recent Development
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Human Coagulation Factor IX Market Trends
Table 176. Human Coagulation Factor IX Market Drivers
Table 177. Human Coagulation Factor IX Market Challenges
Table 178. Human Coagulation Factor IX Market Restraints
Table 179. Human Coagulation Factor IX Distributors List
Table 180. Human Coagulation Factor IX Downstream Customers
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Coagulation Factor IX Product Picture
Figure 2. Global Human Coagulation Factor IX Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Human Coagulation Factor IX Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Human Coagulation Factor IX Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of AHGB
Figure 6. Global AHGB Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of AHFB
Figure 8. Global AHFB Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Global Human Coagulation Factor IX Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Human Coagulation Factor IX Sales Market Share by Type in 2022 & 2034
Figure 13. North America Human Coagulation Factor IX Sales Market Share in Volume by Type in 2022
Figure 14. North America Human Coagulation Factor IX Sales Market Share in Value by Type in 2022
Figure 15. Europe Human Coagulation Factor IX Sales Market Share in Volume by Type in 2022
Figure 16. Europe Human Coagulation Factor IX Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Value by Type in 2022
Figure 19. Latin America Human Coagulation Factor IX Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Human Coagulation Factor IX Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Coagulation Factor IX Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Coagulation Factor IX Revenue in 2022
Figure 25. Human Coagulation Factor IX Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Personal Clinic
Figure 29. Global Personal Clinic Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Global Human Coagulation Factor IX Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Human Coagulation Factor IX Sales Market Share by Application in 2022 & 2034
Figure 34. North America Human Coagulation Factor IX Sales Market Share in Volume by Application in 2022
Figure 35. North America Human Coagulation Factor IX Sales Market Share in Value by Application in 2022
Figure 36. Europe Human Coagulation Factor IX Sales Market Share in Volume by Application in 2022
Figure 37. Europe Human Coagulation Factor IX Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Human Coagulation Factor IX Sales Market Share in Value by Application in 2022
Figure 40. Latin America Human Coagulation Factor IX Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Human Coagulation Factor IX Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Human Coagulation Factor IX Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Human Coagulation Factor IX Manufacturing Cost Structure
Figure 45. Human Coagulation Factor IX Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries